Clark Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Clark Wealth Partners's PFE Position: Q3 2026 in Review
Clark Wealth Partners increased its Pfizer (PFE) stake by 57% in Q3 2026, buying an estimated $4.73K and bringing the position to 489 shares worth $13.9K. The position accounts for 0.01% of the portfolio, ranked #223.
Clark Wealth Partners first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $367K in Q4 2024. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Clark Wealth Partners held 489 shares of Pfizer worth $13.9K as of Q3 2026.
- Clark Wealth Partners bought 178 Pfizer shares in Q3 2026, an estimated $4.73K.
- Pfizer made up 0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #223 holding.
- Clark Wealth Partners first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- Clark Wealth Partners's Pfizer position peaked at $367K in Q4 2024.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.